secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spyre Therapeutics, Inc. (SYRE)
CIK:        0001636282
Form:       8-K
Filed at:   2023-08-11T23:59:59+00:00
Accession:  0001193125-23-209727
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Aeglea BioTherapeutics terminates Austin office lease, pays $2M termination fee
-------------------------------------------------------------------------------

- Terminated lease for Suites 100, 110, and 150 at 805 Las Cimas Parkway, Austin, TX effective Aug 8, 2023.
- Lease originally dated April 30, 2019, amended Oct 2019 and Jan 2020; terminated via agreement with Landlord Las Cimas Owner LP.
- Company paid a termination fee of $2 million as consideration for release from all future obligations under the lease.
- No further obligations to Landlord arise or accrue from and after the Termination Date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636282/000119312523209727/0001193125-23-209727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636282/000119312523209727/d530241d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-209727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer